Portfolio Holdings Detail for ISIN IE00BMX0DF60

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam

Holdings detail for LMAT

Show aggregate LMAT holdings

News associated with LMAT

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Hold” from Analysts

Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have been assigned an average recommendation of “Hold” from the five analysts that are covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target […] - 2025-09-15 04:46:52

Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) PT at $97.60

Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have been given an average recommendation of “Hold” by the five analysts that are covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target […] - 2025-09-15 04:46:48

Peek Under The Hood: SDVY Has 10% Upside

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-11 07:55:13

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $98.00 Consensus Price Target from Analysts

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six brokerages that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year target […] - 2025-08-19 02:16:55

LeMaitre Vascular (NASDAQ:LMAT) Upgraded by Barrington Research to Outperform Rating

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) was upgraded by stock analysts at Barrington Research from a “market perform” rating to an “outperform” rating in a research report issued on Wednesday, MarketBeat.com reports. The brokerage presently has a $95.00 price objective on the medical instruments supplier’s stock. Barrington Research’s target price suggests a potential upside […] - 2025-08-08 02:40:48

LeMaitre Vascular Breaks Above 200-Day Moving Average - Bullish for LMAT

In trading on Wednesday, shares of LeMaitre Vascular Inc (Symbol: LMAT) crossed above their 200 day moving average of $89.93, changing hands as high as $96.14 per share. LeMaitre Vascular Inc shares are currently trading up about 11% on the day. The chart below shows the one y - 2025-08-06 12:48:00

LeMaitre (LMAT) Q2 Revenue Jumps 15%

Key PointsGAAP earnings per share were $0.60 for Q2 2025, beating analyst expectations of $0.57. - 2025-08-06 02:09:32

Lindenwold Advisors INC Sells 330 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Lindenwold Advisors INC lowered its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 11.9% in the first quarter, Holdings Channel reports. The institutional investor owned 2,450 shares of the medical instruments supplier’s stock after selling 330 shares during the period. Lindenwold Advisors INC’s holdings in LeMaitre Vascular were worth $206,000 as […] - 2025-08-01 04:22:55

Alps Advisors Inc. Invests $354,000 in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Alps Advisors Inc. purchased a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,220 shares of the medical instruments supplier’s stock, valued at approximately $354,000. Several other large investors have also modified […] - 2025-07-17 05:28:55

Envestnet Asset Management Inc. Grows Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Envestnet Asset Management Inc. raised its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 9.9% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 285,109 shares of the medical instruments supplier’s stock after buying an additional 25,680 shares during the period. Envestnet Asset […] - 2025-07-16 04:50:54

New York State Teachers Retirement System Has $670,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

New York State Teachers Retirement System lowered its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,989 shares of the medical instruments supplier’s stock after selling 200 shares during […] - 2025-07-11 05:15:00

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas lowered its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 73.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,534 shares of the medical instruments supplier’s stock after selling 75,317 shares during the period. […] - 2025-07-10 05:14:10

State of Alaska Department of Revenue Reduces Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

State of Alaska Department of Revenue lowered its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.3% in the 1st quarter, HoldingsChannel reports. The fund owned 11,337 shares of the medical instruments supplier’s stock after selling 262 shares during the period. State of Alaska Department of Revenue’s holdings in LeMaitre Vascular were worth […] - 2025-06-27 05:06:50

Farther Finance Advisors LLC Decreases Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Farther Finance Advisors LLC cut its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 20.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 783 shares of the medical instruments supplier’s stock after selling 202 shares during the quarter. Farther Finance […] - 2025-06-23 04:26:50

Fifth Third Bancorp Increases Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Fifth Third Bancorp grew its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.3% in the first quarter, HoldingsChannel.com reports. The firm owned 10,903 shares of the medical instruments supplier’s stock after buying an additional 246 shares during the quarter. Fifth Third Bancorp’s holdings in LeMaitre Vascular were worth $915,000 at […] - 2025-06-17 04:51:01

Peek Under The Hood: SDVY Has 12% Upside

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-12 08:30:38

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Two Sigma Advisers LP

Two Sigma Advisers LP trimmed its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 28.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 18,300 shares of the medical instruments supplier’s stock after selling 7,200 shares during the period. Two Sigma Advisers LP’s holdings in LeMaitre Vascular were worth $1,686,000 at the […] - 2025-05-30 05:31:03

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. trimmed its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 62.7% in the fourth quarter, HoldingsChannel reports. The firm owned 18,571 shares of the medical instruments supplier’s stock after selling 31,233 shares during the period. D. E. Shaw & Co. Inc.’s holdings in LeMaitre Vascular […] - 2025-05-22 04:48:46

Captrust Financial Advisors Has $507,000 Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Captrust Financial Advisors decreased its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 11.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,500 shares of the medical instruments supplier’s stock after selling 706 shares during the period. Captrust Financial Advisors’ holdings […] - 2025-05-19 04:52:56

Ex-Dividend Reminder: Select Medical Holdings, LeMaitre Vascular and Selective Insurance Group

Looking at the universe of stocks we cover at Dividend Channel, on 5/15/25, Select Medical Holdings Corp (Symbol: SEM), LeMaitre Vascular Inc (Symbol: LMAT), and Selective Insurance Group Inc (Symbol: SIGI) will all trade ex-dividend for their respective upcoming dividends. Sele - 2025-05-13 12:47:45

Hsbc Holdings PLC Buys 1,170 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Hsbc Holdings PLC grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 43.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,861 shares of the medical instruments supplier’s stock after purchasing an additional 1,170 shares during the quarter. […] - 2025-05-09 05:38:59

LeMaitre Vascular (NASDAQ:LMAT) Trading 4.2% Higher After Dividend Announcement

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) shares shot up 4.2% during trading on Monday following a dividend announcement from the company. The company traded as high as $80.61 and last traded at $82.04. 19,169 shares were traded during trading, a decline of 88% from the average session volume of 162,392 shares. The stock […] - 2025-05-07 02:21:01

Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $98.14

Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have received an average rating of “Moderate Buy” from the eight analysts that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy […] - 2025-04-30 02:34:48

Wells Fargo & Company MN Purchases 2,274 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Wells Fargo & Company MN boosted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 8.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 28,153 shares of the medical instruments supplier’s stock after acquiring an additional 2,274 shares during the quarter. Wells Fargo & Company MN’s holdings in LeMaitre […] - 2025-04-25 04:26:54

Alliancebernstein L.P. Purchases 1,287 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Alliancebernstein L.P. grew its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 6.0% during the 4th quarter, HoldingsChannel reports. The firm owned 22,584 shares of the medical instruments supplier’s stock after acquiring an additional 1,287 shares during the quarter. Alliancebernstein L.P.’s holdings in LeMaitre Vascular were worth $2,081,000 as of its most recent […] - 2025-04-17 04:30:59

Franklin Resources Inc. Grows Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Franklin Resources Inc. grew its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 8.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,678 shares of the medical instruments supplier’s stock after buying an additional 1,032 shares […] - 2025-04-15 04:56:59

Geode Capital Management LLC Purchases 7,737 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Geode Capital Management LLC lifted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 550,260 shares of the medical instruments supplier’s stock after buying an additional 7,737 shares during the […] - 2025-04-14 05:42:55

Envestnet Asset Management Inc. Increases Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Envestnet Asset Management Inc. lifted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 7.0% during the fourth quarter, Holdings Channel reports. The firm owned 259,429 shares of the medical instruments supplier’s stock after acquiring an additional 16,886 shares during the period. Envestnet Asset Management Inc.’s holdings in LeMaitre Vascular were […] - 2025-04-14 04:48:50

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Trexquant Investment LP

Trexquant Investment LP cut its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 3.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 6,066 shares of the medical instruments supplier’s stock after selling 224 shares during the period. Trexquant Investment LP’s holdings in LeMaitre […] - 2025-04-13 07:09:04

Commonwealth Equity Services LLC Sells 2,171 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Commonwealth Equity Services LLC trimmed its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 21.8% during the fourth quarter, Holdings Channel reports. The firm owned 7,794 shares of the medical instruments supplier’s stock after selling 2,171 shares during the quarter. Commonwealth Equity Services LLC’s holdings in LeMaitre Vascular were worth $718,000 as of […] - 2025-04-03 04:20:47

iShares US Medical Devices UCITS ETF LMAT holdings

Date	Number of LMAT Shares Held	Base Market Value of LMAT Shares	Local Market Value of LMAT Shares	Change in LMAT Shares Held	Change in LMAT Base Value	Current Price per LMAT Share Held	Previous Price per LMAT Share Held
2025-09-29 (Monday)	2,999	USD 256,265	USD 256,265	0	USD 3,779	USD 85.4501	USD 84.1901
2025-09-26 (Friday)	2,999	USD 252,486	USD 252,486	0	USD -1,409	USD 84.1901	USD 84.6599
2025-09-25 (Thursday)	2,999	USD 253,895	USD 253,895	184	USD 6,738	USD 84.6599	USD 87.8
2025-09-24 (Wednesday)	2,815	USD 247,157	USD 247,157	0	USD -15,820	USD 87.8	USD 93.4199
2025-09-18 (Thursday)	2,815	USD 262,977	USD 262,977	0	USD 3,687	USD 93.4199	USD 92.1101
2025-09-17 (Wednesday)	2,815	USD 259,290	USD 259,290	0	USD -957	USD 92.1101	USD 92.4501
2025-09-16 (Tuesday)	2,815	USD 260,247	USD 260,247
2025-09-15 (Monday)	2,815	USD 260,022	USD 260,022
2025-09-12 (Friday)	2,815	USD 259,796	USD 259,796

Share Trades of LMAT by Blackrock for IE00BMX0DF60

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-25	BUY	184			84.660*		89.70
2025-06-27	SELL	-44			82.570*		90.28 Profit of 3,972 on sale
2025-06-12	BUY	66			81.370*		90.82
2025-06-10	SELL	-352			83.630*		90.94 Profit of 32,010 on sale
2025-06-09	SELL	-418			83.320*		91.00 Profit of 38,036 on sale
2025-05-30	SELL	-44			82.200*		91.41 Profit of 4,022 on sale
2025-05-19	BUY	22			85.960*		92.14
2025-05-09	SELL	-115			80.260*		92.66 Profit of 10,656 on sale
2025-04-23	SELL	-23			89.540*		93.38 Profit of 2,148 on sale
2025-04-17	SELL	-22			86.280*		93.71 Profit of 2,062 on sale
2025-04-10	BUY	176			81.360*		94.30
2025-04-04	SELL	-44			79.780*		94.98 Profit of 4,179 on sale
2025-04-02	SELL	-44			86.620*		95.08 Profit of 4,183 on sale
2025-03-31	SELL	-66			83.900*		95.34 Profit of 6,292 on sale
2025-03-19	SELL	-22			84.820*		96.54 Profit of 2,124 on sale
2025-02-28	SELL	-44			91.850*		98.86 Profit of 4,350 on sale
2025-02-05	BUY	66			98.530*		98.50
2025-02-04	BUY	88			97.460*		98.53
2025-01-29	SELL	-22			99.920*		98.57 Profit of 2,169 on sale
2025-01-23	SELL	-22			96.310*		98.62 Profit of 2,170 on sale
2025-01-02	SELL	-44			91.470*		98.84 Profit of 4,349 on sale
2024-12-04	BUY	66			104.970*		98.45
2024-12-03	SELL	-22			105.020*		98.21 Profit of 2,161 on sale
2024-12-02	SELL	-264			105.470*		97.93 Profit of 25,852 on sale
2024-11-29	SELL	-440			106.990*		97.56 Profit of 42,928 on sale
2024-11-27	SELL	-66			105.800*		96.85 Profit of 6,392 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LMAT

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer